Jan Škoda, Senior Research Team Leader at Fakultní nemocnice u sv. Anny v Brně (FNUSA) – St. Anne’s University Hospital Brno / FNUSA-ICRC, Associate Professor and Head of Research Group at Masaryk University, shared a post on LinkedIn:
“Are you heading to EACR 2026?
We are waiting to meet you here in Budapest! Let us know and come to see our posters.
Tuesday, 9th June
P-340, ‘Drug repurposing for the therapy of MYC-driven pediatric tumors via mitochondrial synthetic lethality’
Wednesday, 10th June
P-163, Adna Goralija ‘TSR3 ribosome maturation factor associates with aggressive cell states and poor outcomes in neuroblastoma’
P-187, Adela Kubistova ‘Novel cumate-inducible models of MYC-driven neuroblastoma enable mitochondrial synthetic lethality screens without inducer-associated toxicity’
P-380, Vojtech Bartovsky ‘Inhibition of POLRMT reveals mitochondrial transcription as a synthetic lethal target in MYC-driven neuroblastoma’
Very proud of my students and the work they’re going to present.
Looking forward to discussing research and the networking.”
Other articles on OncoDaily.
